Dr. Sheraz Daya is the founder and Chairman of Centre for Sight and was previously Director and Consultant at the Corneoplastic Unit and Eye Bank, Queen Victoria Hospital, East Grinstead (1994-2011). His areas of expertise includes high risk corneal transplantation, limbal stem cell transplantation, lamellar corneal transplantation refractive surgery and high performance lens intraocular lenses. He has published extensively on ocular surface reconstruction and limbal stem cell transplantation. He has also developed novel lamellar transplant techniques. He introduced the femtosecond laser to the UK in 2004 and pioneered its use in corneal transplantation and cataract surgery. Mr Daya is the medical monitor for Technolas – Bausch and Lomb, manufacturers of the Victus and Teneo lasers. A keen writer, he has over 100 publications and is also the founding medical editor of Cataract and Refractive Surgery Today-Europe. He has and continues to serve committees and boards of numerous organizations including ESCRS, UKISCRS, ASCRS, AAO, AECOS, the Royal College of Ophthalmologists and the Corneal Society. 

Financial disclosure: Dr. Daya has/had an affiliation (financial or otherwise) with a commercial organization:

1) Allergan
2) Bausch +Lomb
3) Carl ZeissMeditec
4) CSI
5) Ellex
6) Excellens
7) Johnson & Johnson Vision
8) Lumenis Vision
9) Medicem
10) Nidek, Inc.
11) Omeros
12) Physiol
13) PRN
14) STAAR Surgical
15) Strathspey Crown
16) Scope Pharmaceuticals
17) Tearlab
18) Tearclear